Susan A. King

890 total citations
24 papers, 685 citations indexed

About

Susan A. King is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pharmacology. According to data from OpenAlex, Susan A. King has authored 24 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 4 papers in Pharmacology. Recurrent topics in Susan A. King's work include Chronic Lymphocytic Leukemia Research (4 papers), Biochemical and Molecular Research (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Susan A. King is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Biochemical and Molecular Research (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Susan A. King collaborates with scholars based in United States, Malaysia and Italy. Susan A. King's co-authors include Brian Leyland‐Jones, Jean L. Grem, Peter J. O’Dwyer, Daniel F. Hoth, Richard Leigh, R. Wittes, J. Michael Hamilton, B Leyland-Jones, Susana Martínez‐Conde and Jorge Otero‐Millan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Susan A. King

23 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan A. King United States	15	215	210	112	83	78	24	685
Rachel M.A. Linger United States	8	254 1.2×	359 1.7×	130 1.2×	50 0.6×	77 1.0×	12	1.2k
Leena Peltonen Finland	8	76 0.4×	295 1.4×	95 0.8×	124 1.5×	24 0.3×	9	935
J.H. Peacock United Kingdom	14	168 0.8×	227 1.1×	75 0.7×	176 2.1×	98 1.3×	35	837
Hagit Baris Israel	17	84 0.4×	385 1.8×	158 1.4×	60 0.7×	42 0.5×	49	965
Shiyu Jiang China	13	376 1.7×	209 1.0×	138 1.2×	242 2.9×	32 0.4×	54	767
Mary C. Fletcher United States	15	199 0.9×	566 2.7×	85 0.8×	53 0.6×	25 0.3×	25	1.4k
Helen Travers United Kingdom	11	104 0.5×	448 2.1×	68 0.6×	29 0.3×	254 3.3×	16	905
Lihua Yu China	15	139 0.6×	232 1.1×	53 0.5×	43 0.5×	173 2.2×	54	698
Gilles Alberici France	15	305 1.4×	216 1.0×	118 1.1×	34 0.4×	14 0.2×	33	1.0k
Minden Collamore United States	7	470 2.2×	395 1.9×	66 0.6×	112 1.3×	26 0.3×	8	1.2k

Countries citing papers authored by Susan A. King

Since Specialization

Citations

This map shows the geographic impact of Susan A. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan A. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan A. King more than expected).

Fields of papers citing papers by Susan A. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan A. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan A. King. The network helps show where Susan A. King may publish in the future.

Co-authorship network of co-authors of Susan A. King

This figure shows the co-authorship network connecting the top 25 collaborators of Susan A. King. A scholar is included among the top collaborators of Susan A. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan A. King. Susan A. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCamy, Michael B., Jorge Otero‐Millan, Richard Leigh, et al.. (2015). Simultaneous Recordings of Human Microsaccades and Drifts with a Contemporary Video Eye Tracker and the Search Coil Technique. PLoS ONE. 10(6). e0128428–e0128428. 45 indexed citations

Chen, Athena L., Susan A. King, David E. Riley, et al.. (2011). Influence of orbital eye position on vertical saccades in progressive supranuclear palsy. Annals of the New York Academy of Sciences. 1233(1). 64–70. 5 indexed citations

King, Susan A., et al.. (2011). Critical role of cerebellar fastigial nucleus in programming sequences of saccades. Annals of the New York Academy of Sciences. 1233(1). 155–161. 7 indexed citations

Chen, Athena L., David E. Riley, Susan A. King, et al.. (2010). The Disturbance of Gaze in Progressive Supranuclear Palsy: Implications for Pathogenesis. Frontiers in Neurology. 1. 147–147. 94 indexed citations

Chen, Athena L., Stefano Ramat, Alessandro Serra, Susan A. King, & Richard Leigh. (2010). The role of the medial longitudinal fasciculus in horizontal gaze: tests of current hypotheses for saccade-vergence interactions. Experimental Brain Research. 208(3). 335–343. 11 indexed citations

Grem, Jean L., Susan A. King, Hoo G. Chun, & Michael R. Grever. (1991). Cardiac complications observed in elderly patients following 2′‐deoxycoformycin therapy. American Journal of Hematology. 38(3). 245–247. 16 indexed citations

Grem, Jean L., Susan A. King, John M. Sorensen, & Michaele C. Christian. (1991). Clinical use of thymidine as a rescue agent from methotrexate toxicity. Investigational New Drugs. 9(3). 281–290. 16 indexed citations

Grem, Jean L., et al.. (1990). Clinical toxicity associated with tiazofurin. Investigational New Drugs. 8(2). 227–238. 14 indexed citations

Grem, Jean L., Susan A. King, Mary E. Costanza, & Thomas D. Brown. (1990). Hypersensitivity reactions to trimetrexate. Investigational New Drugs. 8(2). 211–214. 7 indexed citations

10.

Grem, Jean L., Susan A. King, Bruce D. Cheson, B Leyland-Jones, & R. Wittes. (1989). Pentostatin in Hairy Cell Leukemia: Treatment by the Special Exception Mechanism. JNCI Journal of the National Cancer Institute. 81(6). 448–453. 28 indexed citations

11.

Grem, Jean L., Daniel F. Hoth, Brian Leyland‐Jones, et al.. (1988). Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases.. Journal of Clinical Oncology. 6(2). 351–379. 13 indexed citations

12.

Grem, Jean L., Bruce D. Cheson, Susan A. King, Brian Leyland‐Jones, & M Suffness. (1988). Cephalotaxine Esters: Antileukemic Advance or Therapeutic Failure?. JNCI Journal of the National Cancer Institute. 80(14). 1095–1103. 28 indexed citations

13.

O’Dwyer, Peter J., Susan A. King, Jacqueline Plowman, et al.. (1988). Pyrazole: preclinical reassessment. Investigational New Drugs. 6(4). 305–310. 10 indexed citations

14.

Grem, Jean L., Susan A. King, R. Wittes, & Brian Leyland‐Jones. (1988). The Role of Methotrexate in Osteosarcoma. JNCI Journal of the National Cancer Institute. 80(9). 626–655. 38 indexed citations

15.

Grem, Jean L., Susan S. Ellenberg, Susan A. King, & DeWayne Shoemaker. (1988). Correlates of Severe or Life-Threatening Toxic Effects From Trimetrexate. JNCI Journal of the National Cancer Institute. 80(16). 1313–1318. 18 indexed citations

16.

O'Dwyer, P J, Bruce D. Cheson, B Leyland-Jones, Susan A. King, & Daniel F. Hoth. (1988). Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.. PubMed. 2(6). 17–23, 26. 10 indexed citations

17.

Grem, Jean L., Dale Shoemaker, Daniel F. Hoth, et al.. (1987). Arabinosyl-5-azacytosine: A novel nucleoside entering clinical trials. Investigational New Drugs. 5(4). 315–328. 18 indexed citations

18.

O’Dwyer, Peter J., Susan A. King, Daniel F. Hoth, & Brian Leyland‐Jones. (1987). Role of thymidine in biochemical modulation: a review.. PubMed. 47(15). 3911–9. 66 indexed citations

19.

King, Susan A., et al.. (1986). Homoharringtonine--perspectives on an active new natural product.. Journal of Clinical Oncology. 4(10). 1563–1568. 25 indexed citations

20.

O’Dwyer, Peter J., Susan A. King, Clarence L. Fortner, & B Leyland-Jones. (1986). Hypersensitivity reactions to teniposide (VM-26): an analysis.. Journal of Clinical Oncology. 4(8). 1262–1269. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact